Health
Expert Medical Record Reviews Of The Two Girls In Texas Who Purportedly Died of Measles

I have long reviewed medical records of patients harmed by poor medical care. Here, I present clear evidence of what actually caused the 2 girls deaths in Texas. It wasn’t measles.
Before I start, I want all to know that the parents of both children are from the same community and know each other. They and the community are obviously in grief over these unnecessary and easily preventable deaths, which you will learn more about why below. I will state at the outset that, in my professional opinion, neither child died of measles. Not even close.
CASE #1 – Kaley Fehr, Age 6
I will only briefly discuss Kaley’s case because it was already covered extensively in an interview I did with CHD TV a little over two weeks ago. Plus, the record and findings are straightforward.
Kaley was a six-year-old previously healthy girl who contracted measles along with her four siblings (all of whom weathered the illness just fine under the care of Dr. Ben Edwards). As her rash was clearing, she began to develop signs and symptoms of “secondary bacterial pneumonia,” a not uncommon complication of almost any viral infection. To wit, one of my three daughters fell ill with the same after she contracted influenza at age 14; however, in her case, she recovered from it two days after receiving an appropriate antibiotic.
In Kaley’s case, her worsening respiratory status led her parents to bring her to Providence Covenant Children’s Hospital in Lubbock, Texas, on 2/22/25 at 12:08 PM.
The hospital correctly diagnosed her with secondary bacterial pneumonia and then treated her with two antibiotics, ceftriaxone and vancomycin. This was a blatant deviation from the standard of care in treating hospitalized patients with “community-acquired pneumonia (CAP),” the guidelines for which have long recommended a different combination, e.g., ceftriaxone and azithromycin (or a quinolone).
Only azithromycin and quinolones cover mycoplasma pneumonia, a prevalent cause of community-acquired pneumonia (this is why the guidelines recommend them). Neither ceftriaxone nor vancomycin will treat mycoplasma because they work by disrupting the cell walls of bacteria. Mycoplasma does not have a cell wall.
Vancomycin, the antibiotic they chose instead of azithromycin, is used to treat “hospital-acquired pneumonia” as it is one of the only antibiotics that covers MRSA (methicillin-resistant staph aureus). This common organism inhabits hospitals and medical facilities. Kaley was from a rural Mennonite community and had not been in any hospital.
Despite her persistent and increasing deterioration in respiratory status, which eventually led to requiring intubation and mechanical ventilation, this deviation from the standard of care went unnoticed and uncorrected until just over a day before she died, when the test for mycoplasma returned as “positive.”
Azithromycin was then immediately ordered. However, from the chart, it appears it took ten hours before she received her first dose (documentation of the exact time may be missing). She was dead less than 24 hours later, 4 days after being admitted. The time of death was 06:43 on 2/26/25. My opinion as to the cause of death is that it was from an overwhelming lung injury called Acute Respiratory Distress Syndrome (ARDS) caused by mycoplasma pneumonia. The sole reason why she died from mycoplasma was because the initial antibiotic regimen violated the standard of care in the treatment of hospitalized community-acquired pneumonia because they neglected to treat her upon admission with azithromycin (i.e., a “Z-Pak deficiency”).
Note that azithromycin has excellent penetration into lung tissues and is highly effective at treating mycoplasma. Again, had they started azithromycin on Day 1, as has been recommended for decades, she would still be alive today.
The above findings were articulated in my interview with CHD TV on 3/19/25 but were subsequently ignored and/or distorted by the mainstream media. A reporter from USA Today reached out to Rebuild Medicine (my new non-profit) with questions. This is the exchange between my Executive Director and the reporter:
The above text also included links to several CAP guidelines, yet, in the USA Today article that was subsequently written about the case, the reporter 1) took a swipe at my credibility by describing me as a misinformationist, 2) did not even mention the treatment guidelines for community-acquired pneumonia that we had sent him, and 3) included parts of this below statement that the hospital released in response to my video interview. The mendacity of the below statement is astonishing:
“A recent video circulating online contains misleading and inaccurate claims regarding care provided at Covenant Children’s. Patient confidentiality laws preclude us from providing information directly related to this case. What we can say is that our physicians and care teams follow evidence-based protocols and make clinical decisions based on a patient’s evolving condition, diagnostic findings, and the best available medical knowledge. Measles is a highly contagious, potentially life-threatening disease that often creates serious, well-known complications like pneumonia, encephalitis and more.”
CASE #2 – Daisy Hillebrand, Age 8
I received Daisy’s medical records this past Monday via email at 5:55 p.m. Intrigued, I immediately dove in. I began reviewing and taking notes in an Excel spreadsheet because the records were not chronological. The printouts of the electronic medical record totaled 291 pages and came in 6 separate PDF files. It represented the total record for two separate admissions to the ICU of University Medical Center and one to Providence Covenant Children’s Hospital, all again located in Lubbock, Texas.
I worked continuously from 6 p.m. until 1:45 a.m., then put in another 2.5 hours more in the morning. Up until approximately midnight, my working impression of the cause of Daisy’s death was that it indeed was from measles pneumonia. Only after I opened and began reviewing the last file did I find data directly contradicting that impression. I had that initial impression because that was the “working diagnosis” of the ICU team, as documented in their daily notes.
In this case, I will start with my determination of the cause of death in the last admission. Then, I will provide details of the multiple poorly managed hospitalizations (understatement) that she suffered over the 4 weeks leading up to her death.
Cause of death: ARDS secondary to hospital-acquired pneumonia caused by a highly antibiotic-resistant E.Coli “superbug.” Based on the progression and trajectories of her illness, I believe that she contracted the infection from her first ICU admission, which is what caused her to return to the ICU 2 days after that discharge.
One of the tragedies (there were multiple) of this case is that the ICU team in charge of her care when she was re-admitted never considered the possibility of hospital-acquired pneumonia (HAP) until day 6 of 8. For an adult ICU specialist admitting a patient with an infection who was just discharged from an ICU, empiric treatment for hospital-acquired organisms is so basic and routine; I was shocked they did not do this.
In a minor defense of the pediatric team caring for Daisy, there are no published national treatment guidelines with specific antibiotic recommendations for the empiric treatment of hospital-acquired pneumonia (I did find one from the University of North Carolina (UNC), however). The first adult guidelines for HAP were published by the American Thoracic Society in 2005. Here we are 20 years later, and, aside from UNC, the field of pediatrics has not gotten around to doing the same. I found a paper by the Cochrane Library that proposed the methodology for creating one, but although published in 2019, it has not been completed yet. The American Academy of Pediatrics should be ashamed.
The problem for the hospital is that the absence of a treatment guideline is not why she died because had they sent a sputum culture on admission, by Day 3, they would have not only identified the organism but would have learned the antibiotic it was sensitive to and could have started it immediately. Her death on Day 8 would have likely and easily been prevented. Although they did send a urine culture, a blood culture, a viral PCR respiratory panel, and a PCR for MRSA and Staphylococcus (all of which were negative), they did not send a sputum culture. For a pneumonia.
For the sake of brevity, each time I detail a deviation from the standard of care in the below review of all three hospital stays, rather than explaining why it violates the standard in depth (and because I trust it will be evident to even laypeople), I will use baseball terminology by writing “strike” to indicate that “they missed the ball.” The failure to send a sputum culture in a patient with pneumonia who recently spent days in an ICU is Strike 1.
The failure to send a sputum culture had another tragic consequence – it allowed the care team, based on the viral respiratory panel being negative (which does not include measles PCR, by the way), to instead 1) assume that measles was the underlying cause on Day 2 and then, 2) immediately stop antibiotics in a seriously ill and infected child. Strike 2.
In the 8 days of her second hospital admission, she only received 5 days of antibiotics, and that is because, despite a rising white cell count in her blood, they did not restart antibiotics until Day 4, when she spiked yet another fever (Strike 3).
Further, during the three days Daisy received no antibiotics, she was given high-dose steroids. Please know that steroids, when paired with appropriate antibacterials, improve outcomes in pneumonia, but giving them without worsens outcomes. They presumably did this because their working diagnosis was “measles pneumonitis,” not bacterial pneumonia. The doctor in charge kept writing things like: “severe pulmonary sequela of measles infection around 3 weeks ago” and “we are concerned that the true extent of her lung injury due to measles is unknowable and it may be an end-stage process given the span of illness and the fact she truly is an outlier.” I don’t know what that last part means except that the clinical reasoning is unclear, and a broader “differential diagnosis” was not generated. At all.
Know that I have long taught my ICU residents and fellows the two guideposts that governed my care plans for critically ill patients. The first is, “If what you are doing is working, keep doing what you are doing.” This means that if their clinical trajectory was one of slow or steady improvement, sending endless diagnostic tests or adding therapies just because they were still ill is most often unnecessary.
The other was, “If what you are doing is not working, change what you are doing.” In this situation, I would re-review all the clinical data and further explore any causes I might be missing, or I would add on treatments that, although not standard, might offer benefit. I would try anything that might turn someone around, as long as the risk/benefit profile was favorable (when someone is persistently deteriorating, risk/benefit ratios change rapidly such that almost any treatment that holds the possibility for benefit is worthwhile to prevent death). In my opinion, at least.
With that in mind, I will say that I was encouraged by the one instance I found of the team “thinking outside the box” and trying a somewhat experimental treatment. They decided to give her intravenous immunoglobulin (IVIG)! One trial from China in 2015 found that IVIG improved outcomes in children with severe pneumonia (not measles-specific), and another study found that IVIG batches tested in 2021 contained measles-neutralizing antibodies. Good for them for trying something “off protocol.” Problem: they did not give her the IVIG until Day 7, one day before death.
Also, it was not until one day after re-starting antibiotics (Day 6) that they sent a sputum culture (Strike 4 – standard practice is to send a culture at the same time you start antibiotics). This was also the first time the thought that she might have HAP appeared in the record. This thought led them to then change her antibiotic to one that is routinely used for possible HAP (ceftazidime). Problem: The adult guidelines would have dictated that they start Imipenem or Meropenem, but since they don’t have a pediatric guideline published yet, I will not give them a strike for this.
Two days later, on Day 8, she died of refractory hypoxemia – they could no longer get oxygen into her blood via her lungs despite numerous heroic mechanical ventilation maneuvers. This, to me, is a condition that is akin to drowning in pus.
A few hours after her death, the sputum culture they sent on Day 6 was reported in the record (this is what caused me to change my working diagnosis as to the cause of her pneumonia). My jaw dropped as I read it: It showed 4+ growth of “E.Coli,” a nasty bug generally found in our GI tract only. If you don’t know what 4+ means, see this chart below, which explains the “semi-quantitative growth scale” for bacterial cultures:
If you think this can’t get any worse, you would be wrong: next came the panel of susceptibilities to a slew of antibiotics. Read it and weep:
Ampicillin – Resistant, Ampicillin/Sulbactam – Resistant, Aztreonam – Resistant, Cefazolin – Resistant, Cefepime – Resistant, Cefoxitin – Resistant, Ceftriaxone – Resistant, Cefuroxime- Resistant, Ciprofloxacin – Resistant, Levofloxacin – Resistant, Piperacillin – Resistant, Tetracycline – Resistant, Tobramycin – Resistant, and finally and tragically, Ceftazidime- Resistant.
It was sensitive to only a handful of antibiotics, one of which was meropenem, which is what would have been recommended by the Adult HAP Guidelines. Daisy had numerous risk factors for HAP (previous antibiotics, previous ICU, immunosuppressed, really sick, mechanically ventilated). In conclusion, an appropriate differential diagnosis for her pneumonia did not occur until Day 5, and a sputum culture was sent too late for them to discover that the antibiotic they selected was resistant to the organism she died from.
I am going to temporarily interrupt this post to warn you that, in the below reviews of the two hospital admissions she underwent in the week before the above “final” one, the above pattern of error-prone care and missed opportunities to save her life will continue.
HOSPITAL ADMISSION AT UMC 2 DAYS BEFORE THE FINAL ICU STAY
In this hospitalization, which began on 3/21/25, 6 days before the above admission, Daisy presented with typical symptoms of pneumonia along with a chest x-ray showing a left lower lobe process, classic for bacterial pneumonia. Her admitting diagnosis was “viral illness with probable secondary bacterial pneumonia.” Just like in Kaley Fehr’s case at Covenant Hospital, at UMC, they also decided to treat Daisy with the same inexplicable and standard-violating combination of ceftriaxone and vancomycin. Strike 1. However, Daisy did not suffer the same fate as Kaley because whatever bug was making her ill at this point, it appeared that it was sensitive to this combination, plus her mycoplasma test was negative. Near miss though. Not all medical errors lead to harm, and malpractice cannot be established without harm.
Although the mother was not aware that Daisy had a subtle rash on her back on admission, the ER physician suspected it was measles and sent off a PCR test, which returned positive on the day of discharge. OK, so she had measles too.
She was pretty sick lung-wise at first because she required admission to the ICU for oxygen support. However, her oxygen requirements decreased pretty quickly, her appetite improved, her rash began to “heal and fade,” and she was discharged home on oral antibiotics on Day 4. They prescribed her oral cefdinir, which was a fine choice, in my opinion, because she had responded to ceftriaxone in the hospital (a similar antibiotic).
Problem: in the discharge note, the doctor documented that “the parents appeared concerned” with the discharge and then reported that he/she had “reassured them.” Privately, Daisy’s father told me that was the same day her measles test came back positive, and he thinks that is why they sent her out so quickly. He felt she “didn’t look too good” and was concerned. I would have to agree with him based on the fact that she quickly began to get worse upon arriving home such that 2 days later, on 3/26/25, she had to return to the ER to be readmitted with what turned out to be the fatal E.Coli pneumonia episode I detailed above. My thought: she was beginning to fall ill with E.Coli pneumonia as she was being discharged (resistant to the cefdinir she left with).
I hope you have noticed that I have not overused the phrase, “If you think that was bad, it only gets worse.” If you allow me, I will invoke that phrase again here. Read on:
ADMISSION TO COVENANT HOSPITAL TWO DAYS PRIOR TO THE ABOVE UMC ADMISSIONS
If the sequence of events is confusing because I am “going back in time,” let’s change it up and start from the beginning so I can provide you with the timeline from the beginning of her illnesses.
Daisy had a history of chronic tonsillitis and was being scheduled for a tonsillectomy. A month before her death, as per Dr. Richard Bartlett, Daisy was diagnosed with mononucleosis and developed persistent fevers, which continued throughout the month, including all her hospital admissions. Daisy’s father told me that at one point in the first few weeks, she was also diagnosed and treated for strep at another facility, which Dr. Bartlett thinks was Seminole Hospital District (I don’t have the records for that visit). Then, late in the third week of her illnesses, she was admitted to Covenant Children’s Hospital in Lubbock, stayed one night, and was discharged. 2 days later, she was admitted to UMC for the first of her two hospital admissions there. We good with the timeline?
Now, we have to talk about what happened during her one-night stay at Covenant because had she been appropriately treated there, she would never have ended up at UMC, and all of the above would have been avoided.
Briefly, on 3/18/25, she was at a community health clinic where they found her to require oxygen, so she was sent to the ER. She complained of difficulty breathing, abdominal pain, nausea, and inability to eat and was found with thrush on exam. She had a recent Tmax of 103.7. A CT scan of the abdomen and chest was done, which found splenomegaly and a left lower lobe pneumonia surrounded by a small amount of fluid (e.g., a pleural effusion).
She was given IV ceftriaxone (no azithromycin – Strike), corticosteroids, a breathing treatment (albuterol), and a painkiller (Toradol). This was in the ER, and I do not have the records from the ER, just the hospital stay. She was then admitted to Covenant Children’s Hospital with the diagnosis of pneumonia with a “plan to transition to oral antibiotics in the a.m.” Strike 1 for the absence of azithromycin in her regimen. Again. 3rd hospital this has happened at in my reviews of these cases (someone please call the Department of Health in Texas). No sputum culture was ordered, although a blood culture was. Strike 2.
She was given oral amoxicillin and IV ceftriaxone (unnecessarily redundant coverage but not a strike), Motrin, and Tylenol (ugh, but not a strike). By the next day, her oxygen levels had improved, and she was eating OK, so they discharged her. Problem: the only medication she was discharged with, per the record, was the anti-fungal drug nystatin for the thrush. No antibiotics for her pneumonia. Strike 3, and I really mean Strike 3.
What? The only possible defense is that someone forgot what the CT showed (it appears the ED is separate from the hospital) and instead went by the chest X-ray (CXR) they did in the hospital. Why you would do a CXR on the same day she had a CT is beyond me (CTs are much more sophisticated and detailed).
I suspect the CXR caused the problem because it only revealed bronchial wall thickening. It missed the lower lobe process seen on CT, which is not uncommon as CXRs are much less sensitive to diagnosing pneumonia than CTs. The radiologist stated in his report that “bronchial wall thickening can be seen in asthma or viral illnesses.”
Below is the email with my preliminary findings that I sent to Brian Hooker, Chief Scientific Officer at Children’s Health Defense
I did a quick review, not detailed, but this is what I came up with, and I am again absolutely gobsmacked:
1) I can find no lab work in the chart; it appears from her discharge they did not do any
2) The admission note mentions a CT of the abdomen and chest. The CT abdomen revealed splenomegaly, and the CT Chest revealed a lower lobe opacity and a small pleural effusion. The reports are not included; I think they were done in another facility. The CT is diagnostic of bacterial pneumonia ( focal process with an effusion—i.e., not viral).
3) She was given antibiotics while in hospital but not upon discharge
OVERALL IMPRESSION: Left lower lobe bacterial pneumonia and thrush indicating an immunosuppressed status. They gave her one day of antibiotics for this bacterial pneumonia and then discharged her without an oral antibiotic regimen. She was discharged on 3/19. Two days later (3/21) was her first hospitalization to UMC… for a left lower lobe pneumonia, which landed her in the ICU. To me, this is a clear case of a “missed diagnosis.” Had she been given appropriate oral antibiotics upon discharge, the slow-moving train wreck at UMC would likely have been avoided. There are no words for this. I advise any parent or guardian of a young child to move from that area of Texas immediately in the event they ever need competent medical care. This is almost certainly a separate instance of medical malpractice for which this hospital and its pediatricians could be held liable.
Can you guys find out where the CAT scans were done and get records from that visit? It sounds like it was an outside ER or free-standing ER.
My short, narrative summary of what happened to poor Daisy:
Daisy became ill with mononucleosis a month before death, soon followed by a strep infection and then thrush. Fevers persisted throughout, and then three weeks after the mono diagnosis, she was admitted to Covenant Childrens, diagnosed with left lower lobe pneumonia, and treated successfully. However, she was sent home without oral antibiotics. Unsurprisingly, 2 days later, she was admitted to UMC’s ICU with measles and a worsening left lower lobe pneumonia, which was again, despite errors in antibiotic selection, successfully treated, and she was discharged despite concerns by her parents. The measles rash was clearing at this point. Then, 2 days after that, she was re-admitted to UMC’s ICU with a worsening CXR (now involving her right lung) and severely worsened oxygenation. Instead of suspecting a severe hospital-acquired bacterial infection and sending a sputum culture, the presumptive diagnosis was that her lungs were failing from measles pneumonia, and her antibiotics were stopped. She was instead given corticosteroids for “measles pneumonitis.” She continued to deteriorate despite their re-starting antibiotics on Day 4 and giving IVIG on Day 7. She died on Day 8 of what a few hours later was discovered to be a large amount of E.Coli in her sputum that was highly resistant to the antibiotics she was on.
I largely (and atypically for me as a writer) left out the many emotions I felt while writing this review. I will write a separate post to explore my thoughts about these two cases and why I think hospital care is deteriorating throughout the country, and not just in pediatrics. Recent papers have documented significant decreases in Americans’ trust in their hospitals and doctors (and media) compared to before Covid.
Further, these cases are being widely and repeatedly portrayed as “measles deaths” by a pharma-controlled press in an attempt to regenerate enthusiasm for vaccines (IMO by instilling exaggerated fears of measles (over 90% of measles cases are benign, and most complications can be easily treated with competent medical care). If the media continues to do this fear-mongering by using cases of non-measles deaths, public trust will plummet even further (or maybe I should say public distrust will skyrocket further).
I want to thank Dr. Ben Edwards and Dr. Richard Bartlett, who are in Lubbock doing everything they can to keep kids out of the hospital by delivering appropriate and effective outpatient care.
If you appreciate the pro-bono time and effort I put into performing these extensive case reviews and
researching and writing my posts, please consider a paid subscription.
Daily Caller
Daily Caller EXCLUSIVE: Trump’s Broad Ban On Risky Gain-Of-Function Research Nears Completion

From the Daily Caller News Foundation
By Emily Kopp
President Donald Trump could sign a sweeping executive order banning gain-of-function research — research that makes viruses more dangerous in the lab — as soon as May 6, according to a source who has worked with the National Security Council on the issue.
The executive order will take a broad strokes approach, banning research amplifying the infectivity or pathogenicity of any virulent and replicable pathogen, according to the source, who requested anonymity to speak candidly about the anticipated executive action. But significant unresolved issues remain, according to the source, including whether violators will be subject to criminal penalties as bioweaponeers.
The executive order is being steered by Gerald Parker, head of the White House Office of Pandemic Preparedness and Response Policy, which has been incorporated into the NSC. Parker did not respond to requests for comment.
Dear Readers:
As a nonprofit, we are dependent on the generosity of our readers.
Please consider making a small donation of any amount here. Thank you!
In the process of drafting the executive order, Parker has frozen out the federal agencies that have for years championed gain-of-function research and staved off regulation — chiefly Anthony Fauci’s former institute, the National Institute of Allergy and Infectious Diseases at the National Institutes of Health.
The latest policy guidance on gain-of-function research, unveiled under the Biden administration in 2024, was previously expected to go into effect May 6. According to a March 25 letter cosigned by the American Society for Microbiology, the Association for Biosafety and Biosecurity International, and Council on Governmental Relations, organizations that conduct pathogen research have not received direction from the NIH on that guidance — suggesting the executive order would supersede the May 6 deadline.
The 2024 guidance altered the scope of experiments subject to more rigorous review, but charged researchers, universities and funding agencies like NIH with its implementation, which critics say disincentivizes reporting. Many scientists say that researchers and NIH should not be the primary entities conducting cost–benefit analyses of pandemic virus studies.
Parker previously served as the head of the National Science Advisory Board for Biosecurity (NSABB), a group of outside experts that advises NIH on biosecurity matters, and in that role recommended that Congress stand up a new government agency to advise on gain-of-function research. Former Centers for Disease Control and Prevention Director Robert Redfield has also endorsed moving gain-of-function research decision making out of the NIH to an independent commission.
“Given the well documented lapses in the NIH review process, policymakers should … remove final approval of any gain-of function research grants from NIH,” Redfield said in a February op-ed.
It remains to be seen whether the executive order will articulate carveouts for gain-of-function research without risks of harm such as research on non-replicative pseudoviruses, which can be used to study viral evolution without generating pandemic viruses.
It also remains to be seen whether the executive order will define “gain-of-function research” tightly enough to stand up to legal scrutiny should a violator be charged with a crime.
Risky research on coronaviruses funded by the NIH at the Wuhan Institute of Virology through the U.S. nonprofit EcoHealth Alliance typifies the loopholes in NIH’s existing regulatory framework, some biosecurity experts say.
Documents obtained through the Freedom of Information Act in 2023 indicated that EcoHealth Alliance President Peter Daszak submitted a proposal to the Pentagon in 2018 called “DEFUSE” describing gain-of-function experiments on viruses similar to SARS-CoV-2 but downplayed to his intended funder the fact that many of the tests would occur in Wuhan, China.
Daszak and EcoHealth were both debarred from federal funding in January 2025 but have faced no criminal charges.
“I don’t know that criminal penalties are necessary. But we do need more sticks in biosafety as well as carrots,” said a biosecurity expert who requested anonymity to avoid retribution from his employer for weighing in on the expected policy. “For instance, biosafety should be a part of tenure review and whether you get funding for future work.”
Some experts say that it is likely that the COVID-19 crisis was a lab-generated pandemic, and that without major policy changes it might not be the last one.
“Gain-of-function research on potential pandemic pathogens caused the COVID-19 pandemic, killing 20 million and costing $25 trillion,” said Richard Ebright, a Rutgers University microbiologist and longtime critic of high-risk virology, to the Daily Caller News Foundation. “If not stopped, gain-of-function research on potential pandemic pathogens likely will cause future lab-generated pandemics.”
Health
WHO member states agree on draft of ‘pandemic treaty’ that could be adopted in May

From LifeSiteNews
The WHO draft ‘pandemic accord’ includes data sharing between governments and pharmaceutical companies to develop ‘pandemic-related health products,’ though it would not apply to the US.
Representatives of WHO member states have agreed on a draft of the “pandemic accord” that is scheduled to be voted on next month.
“The nations of the world made history in Geneva today,” Dr. Tedros Adhanom Ghebreyesus, Director-General of the WHO, said after the member states agreed on the draft of the pandemic treaty on Wednesday.
“In reaching consensus on the Pandemic Agreement, not only did they put in place a generational accord to make the world safer, they have also demonstrated that multilateralism is alive and well, and that in our divided world, nations can still work together to find common ground, and a shared response to shared threats. I thank WHO’s Member States, and their negotiating teams, for their foresight, commitment and tireless work. We look forward to the World Health Assembly’s consideration of the agreement and – we hope – its adoption,” the WHO leader continued.
The agreement was reached by the Intergovernmental Negotiating Body (INB), the committee set up by the WHO to negotiate the treaty, after more than three years of negotiations.
According to the WHO’s press release, the core pandemic treaty draft includes the establishment of “a pathogen access and benefit sharing system,” allowing the sharing of data between governments and pharmaceutical companies aimed at quickly developing and supplying “pandemic-related health products” during a pandemic. These “health products” could be dangerous mRNA injections, similar to those rolled out and imposed on large parts of the world population during the COVID-19 crisis.
The WHO claims that the “proposal affirms the sovereignty of countries to address public health matters within their borders, and provides that nothing in the draft agreement shall be interpreted as providing WHO any authority to direct, order, alter or prescribe national laws or policies, or mandate States to take specific actions, such as ban or accept travellers, impose vaccination mandates or therapeutic or diagnostic measures or implement lockdowns.”
The WHO seems to be responding to critics of the Pandemic Treaty, who have argued it is a power grab by the WHO. It would give the global organization unchecked power whenever it declares that any health risk is a “pandemic.” However, the new draft has not yet been made public, making a thorough assessment impossible.
WHO director-general Ghebreyesus engaged in his typical fear-mongering, stating, “Virus is the worst enemy. (It) could be worse than a war.”
READ: WHO director Tedros calls for ‘more aggressive’ action against COVID shot critics
While the WHO pandemic treaty and the amendments to the International Health Regulations (IHR) failed to pass last year, the new version of the agreement could be passed by a two-thirds majority at the annual World Health Assembly (May 19-27, 2025) next month.
However, the U.S. was not part of the negotiations and would not be bound by the agreement since President Donald Trump withdrew the country from the international body in January 2025 after taking office for his second term. Argentine President Javier Milei announced in February that his country will also leave the WHO, following Trump’s example. If more countries were to leave the WHO, the pandemic agreement could be ineffective in practice, even if it were to pass in May.
-
2025 Federal Election2 days ago
RCMP Whistleblowers Accuse Members of Mark Carney’s Inner Circle of Security Breaches and Surveillance
-
Also Interesting2 days ago
BetFury Review: Is It the Best Crypto Casino?
-
Autism2 days ago
RFK Jr. Exposes a Chilling New Autism Reality
-
COVID-192 days ago
Canadian student denied religious exemption for COVID jab takes tech school to court
-
2025 Federal Election2 days ago
Bureau Exclusive: Chinese Election Interference Network Tied to Senate Breach Investigation
-
International2 days ago
UK Supreme Court rules ‘woman’ means biological female
-
2025 Federal Election2 days ago
Neil Young + Carney / Freedom Bros
-
Health2 days ago
WHO member states agree on draft of ‘pandemic treaty’ that could be adopted in May